Influenza, Human: all 2,265 studies
Page 17 of 23. Open to participants first (174), then studies with results posted, then the rest; newest registration first within each.
- Use of Probiotics to Prevent InfluenzaCompletedNCT01720329Not applicable
- Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for InfluenzaStatus unknownNCT01719874Phase 2
- A Pharmacokinetic/Pharmacodynamic Study of Oseltamivir in Immunocompromised Children With Confirmed Influenza InfectionCompletedNCT01715909Phase 1
- Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UKCompletedNCT01715792
- Evaluating Modes of Influenza TransmissionCompletedNCT01710111Not applicable
- Response to Influenza Vaccination in Lymphoma Patients Treated With RituximabCompletedNCT01707628Not applicable
- Routes of Immunization and Flu Immune ResponsesCompletedNCT01707602Phase 1/2
- Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older AdultsCompletedNCT01701752Phase 1
- Optimizing Influenza Vaccination in Surgical Oncology PatientsStatus unknownNCT01698177Phase 4
- Effectiveness Assessment of Vaccinating Schoolchildren Against InfluenzaCompletedNCT01693380Phase 4
- Panama and El Salvador Children's Oseltamivir StudyTerminatedNCT01690637Phase 4
- Safety Study of an Oral Vaccine to Prevent Seasonal InfluenzaCompletedNCT01688297Phase 1
- Nasal Specimen Collection Study in Patients With ILI and/or ARI in an Outpatient SettingStatus unknownNCT01687816
- Efficacy and Safety of Influenza Vaccine During SarcoidosisCompletedNCT01687517Phase 3
- ADITEC FLU STUDY: Understanding the Genetic Basis for Immune ResponsesCompletedNCT01682369Phase 2
- Influenza Immunization of Children in IndiaCompletedNCT01680679Phase 4
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former SmokersCompletedNCT01678677Phase 1
- Study of Yili Mei Yi Tian Active Lactobacillus Drink to Improve Immunity and Digestive SystemCompletedNCT01677715Not applicable
- Study of Yili Lactoferrin ShuHua Milk in the Improvement of Human ImmunizationCompletedNCT01677702Not applicable
- Safety, Tolerability and Immunogenicity of Two Different Formulations of an Influenza A Vaccine (FP-01.1)CompletedNCT01677676Phase 1
- A Phase I Clinical Trial With Whole Virus Inactivated Influenza H5N1 Vaccine in Healthy Adolescents and AdultsWithdrawnNCT01676675Phase 1
- Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 YearsCompletedNCT01676402Phase 1
- A Phase I Study to Evaluate the Safety, Reactogenicity, and Humoral Immune Responses to an Inactivated H5N1 Influenza VaccineCompletedNCT01675284Phase 1
- Study of Immune Responses in Healthy Adults Receiving Live Influenza Virus VaccinesCompletedNCT01674205Phase 1
- Infliximab IBD Influenza Vaccine StudyCompletedNCT01666535Not applicable
- Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of AgeCompletedNCT01659086Phase 1
- Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49CompletedNCT01658800Phase 1
- H5-VLP + GLA-AF Vaccine Trial in Healthy Adult VolunteersCompletedNCT01657929Phase 1
- Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) VaccineCompletedNCT01657526Phase 1
- Safety and Immunogenicity Study of Split Influenza Virus Vaccine in Different Age GroupsCompletedNCT01654809Phase 4
- Live Versus Inactivated Influenza Vaccine Study in Hutterite ChildrenCompletedNCT01653015Phase 4
- A Study of Arbidol (Umifenovir) for Treatment and Prophylaxis of Influenza and Common ColdStatus unknownNCT01651663Phase 4
- Influenza Antiviral DAS-181-F04 in Healthy AdultsCompletedNCT01651494Phase 1
- Yearly Licence Tolerability and Immunogenicity Study of Fluval AB Seasonal Influenza Vaccine to be Used in the 2012/2013 Vaccination SeasonCompletedNCT01649713Phase 4
- Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy AdultsCompletedNCT01640691Phase 1/2
- Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 2012/2013 SeasonCompletedNCT01633749Phase 3
- A Phase I Study to Determine the Safety and Immunogenicity of the Candidate Influenza Vaccine ChAdOx1-NP+M1CompletedNCT01623518Phase 1
- MAS-1 Adjuvanted Compared to Unadjuvanted Influenza Vaccines in the ElderlyWithdrawnNCT01623232Phase 1/2
- Effectiveness of H1N1 Influenza Vaccines in Manitoba, CanadaStatus unknownNCT01622491
- Clinical Study for Safety and Immunogenicity Study of Influenza VaccineCompletedNCT01617239Phase 1
- Safety and Efficacy Study of Nitazoxanide in the Treatment of Acute Uncomplicated InfluenzaCompletedNCT01610245Phase 3
- Seasonal Influenza DNA Vaccine & Seasonal Influenza Trivalent Inactivated Vaccine (TIV) in Children & AdolescentsCompletedNCT01609998Phase 1
- Influenza Burden Assessment in the United States, July1997 - up to April 2009CompletedNCT01599390
- A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 2CompletedNCT01596725Phase 1
- A/H5N1 Virus-Like Particle Antigen Dose Ranging Study With Adjuvant 1CompletedNCT01594320Phase 1
- Safety Study of FluMist With and Without AmpligenTerminatedNCT01591473Phase 1/2
- DNA-based Influenza Vaccine in the ElderlyCompletedNCT01587131Phase 1
- Adjuvanted Influenza Vaccine Evaluation in Kidney Transplant RecipientsCompletedNCT01584908
- Assessment of Needle-free Disposable-syringe Jet Injector (DSJI) ID Dose-sparing of Pandemic A H1N1 Influenza VaccineStatus unknownNCT01582633Phase 2/3
- Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate VaccineCompletedNCT01580033Phase 3
- Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant WomenStatus unknownNCT01577316Phase 2/3
- H5N1 Vaccination With and Without AS03: Systems Biology AnalysisCompletedNCT01573312Phase 1
- Post-marketing Clinical Observation of an Inactivated Influenza Split VaccineCompletedNCT01568788Not applicable
- A Study to Investigate VX-787 Given to Adult Volunteers Inoculated With Live Influenza VirusCompletedNCT01561807Phase 2
- A Study to Evaluate the Immune Response and Safety of a Seasonal Virus-Like Particle Influenza Vaccine in Healthy Young AdultsCompletedNCT01561768Phase 2
- Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49 YearsCompletedNCT01560793Phase 1
- Clinical Trial of the Inactivated Influenza Vaccine (0.25ml Formulation for Pediatric Use)CompletedNCT01554826Phase 3
- Clinical Trial of Inactivated Influenza Vaccine (0.5ml Formulation)CompletedNCT01554813Phase 3
- The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated) （Children Forms of Drug）CompletedNCT01551823Phase 3
- The Clinical Trial Protocol for the Influenza Virus Vaccine (Split Virion, Inactivated)CompletedNCT01551810Phase 3
- Oseltamivir for Influenza Lower Respiratory Tract Infection in Children Under OneWithdrawnNCT01546935Phase 2/3
- Safety of Lactobacillus Rhamnosus GG Versus Placebo in Elderly Subjects Receiving Live Attenuated Influenza VaccineCompletedNCT01545349Phase 1
- Immunogenicity of Influenza Vaccines in HIV-infected Persons in ThailandCompletedNCT01538940Phase 4
- Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy AdultsCompletedNCT01534468Phase 1
- Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant WomenCompletedNCT01527825Phase 3
- Cost of Illness Associated With Influenza in the UKCompletedNCT01521416
- Influenza Burden Assessment in the United Kingdom, 1996-2008CompletedNCT01520935
- Sentinel Surveillance for Influenza Requiring Hospital Admission Canadian AdultsCompletedNCT01517191
- The Safety and Immune Response to Influenza Vaccination in Pregnant WomenCompletedNCT01514708Phase 4
- Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine,Formulation 2011-2012, in Dialysis PatientsStatus unknownNCT01512056Phase 4
- Phase IV Clinical Trial of an Inactivated Influenza Split VaccineCompletedNCT01511744Phase 4
- Intradermal Trivalent Influenza Vaccine With ImiquimodCompletedNCT01508884Not applicable
- Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV AloneCompletedNCT01498718Phase 1
- Maternal Immunization: Giving Immunity For TomorrowCompletedNCT01496079
- Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in InfantsCompletedNCT01494740Phase 2
- Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and YouthCompletedNCT01484522
- Evaluation of an Influenza Vaccination Implementation Strategy for Hospital Health Care WorkersStatus unknownNCT01481467Not applicable
- Study of a Quadrivalent Influenza Vaccine Administered Intramuscularly in Children/Adolescents and AdultsCompletedNCT01481454Phase 3
- A Study of Exclusion Criteria in a University PopulationCompletedNCT01472536Not applicable
- Influenza Vaccination in Fibromyalgia PatientsStatus unknownNCT01465477Not applicable
- A Study to Determine the Safety and Immunogenicity of Co-administration of the Candidate Influenza Vaccine MVA-NP+M1 and Seasonal Influenza VaccineCompletedNCT01465035Phase 1
- Safety of Inhaled Zanamivir in PregnancyCompletedNCT01462487
- A Study to Evaluate Safety and Immunogenicity of FluvalAB-like Influenza Vaccine in Non-Elderly Adult and Elderly SubjectsCompletedNCT01459276Not applicable
- Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in ChinaCompletedNCT01459081Phase 3
- A Study to Assess Immunogenicity Parameters After Vaccination Against Influenza and to Evaluate How These Parameters Change During the Influenza SeasonCompletedNCT01457027Phase 4
- The Effect of Proximity on Flu-Shot ParticipationCompletedNCT01455753
- Study of Parenterally Administrated Adjuvanted Seasonal Influenza Vaccine in Healthy Elderly VolunteersStatus unknownNCT01444482Phase 1
- Experimental AD4-H5-VTN Vaccine in Healthy VolunteersCompletedNCT01443936Phase 1
- Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza VaccineCompletedNCT01443663Phase 1
- Seasonal Influenza Vaccine Effectiveness Study in KenyaCompletedNCT01432340
- Validation of the Respirio Flu Test for the Rapid Identification of Influenza A/BCompletedNCT01431768Not applicable
- Seasonal Influenza Vaccination Reminders for Children With High-risk ConditionsCompletedNCT01431183Not applicable
- Maternal Flu Vaccine Trial in Bamako, MaliCompletedNCT01430689Phase 4
- Phase1 Study of GR121167, Single and Multiple Dose Study in Healthy Japanese MalesCompletedNCT01428479Phase 1
- Adjuvanted Influenza Vaccine Effectiveness in the Elderly (65+Yrs)Status unknownNCT01424371
- Safety and Immunogenicity of One Dose of a Surface, Antigen, Inactivated, Influenza Vaccine Produced in Mammalian Cell Culture Administered to Adult and Elderly SubjectsCompletedNCT01422512Phase 3
- H1N1 Vaccine Safety in Manitoba, CanadaStatus unknownNCT01421251
- A Study to Assess the Safety and Immunogenicity of M-001 Influenza Vaccine as a Primer to TIV in Elderly VolunteersCompletedNCT01419925Phase 2
- Characterization of Influenza-like Illness in MexicoCompletedNCT01418287
- A Systematic Review of Studies of the Effect of Influenza Vaccine Against Mismatched StrainsCompletedNCT01416597